StockClub

INMB

INMBINmune Bio, Inc.$ --
INmune Bio, Inc.

INmune Bio, Inc.

INMB

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -100.0%
Operating Income
-6M USD
YoY +41.3%
Net Income
-5M USD
YoY +44.5%
EPS
-0.2$
YoY +53.5%

Revenue

$0
FY2024 Q2$14,000
$14,000
Q2
FY2024 Q3$14,000
$14,000
Q3
FY2024 Q4$14,000
$14,000
Q4
FY2025 Q1$50,000
$50,000
Q1
FY2025 Q2$50,000
$50,000
Q2
FY2025 Q3$50,000
$50,000
Q3
FY2025 Q4$50,000
$50,000
Q4
FY2026 Q1$0
$0
Q1
Actual
$-50,000 (-100.0%)

Net Income

$-5.4M
FY2024 Q2$-20.8M
$-20.8M
Q2
FY2024 Q3$-32.9M
$-32.9M
Q3
FY2024 Q4$-42.1M
$-42.1M
Q4
FY2025 Q1$-9.7M
$-9.7M
Q1
FY2025 Q2$-34.2M
$-34.2M
Q2
FY2025 Q3$-40.7M
$-40.7M
Q3
FY2025 Q4$-45.9M
$-45.9M
Q4
FY2026 Q1$-5.4M
$-5.4M
Q1
Actual
+$4.3M (+44.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$11,000
FY2020
$11,000
FY2021BEAT
Actual:$181,000
Est:$10,667
FY2021BEAT
$181,000
FY2022BEAT
Actual:$374,000
Est:$195,500
FY2022BEAT
$374,000
FY2023BEAT
Actual:$155,000
Est:$85,000
FY2023BEAT
$155,000
FY2024BEAT
Actual:$14,000
Est:$7,000
FY2024BEAT
$14,000
FY2025MISS
Actual:$50,000
Est:$75,000
FY2025MISS
$50,000

Analyst Estimates